07/03/20

KDx Diagnostics Announces CE Marking for Innovative Non-invasive URO17™ Bladder Cancer Test

KDx Diagnostics, Inc., announced today that it has received Conformité Européene (CE) Marking for its innovative and proprietary urine-based test (the URO17™ test) for bladder cancer... more

01/08/20

KDx Diagnostics announces FDA Breakthrough Device designation for URO17™, Innovative urine test 

CAMPBELL, Calif., Jan. 8, 2020 /PRNewswire/ -- KDx Diagnostics, Inc. (KDx), announced today that the Food and Drug Administration (FDA) has granted "Breakthrough Device" designation for its URO17™ Bladder Cancer Recurrence Test... more

11/03/19

Demonstration of Keratin 17 Biomarker for Urothelial Carcinoma Detection

Bladder carcinoma is a common urological cancer with high morbidity, mortality, and recurrence rates requiring frequent, invasive diagnostic procedures...more(1) more(2) 

10/08/19

A Better Future 

A new biomarker allows effective, noninvasive screening of patients at risk of the disease. Bladder cancer presents a diagnostic challenge for even the best pathologists and laboratory medicine professionals...more

7/25/19

Acupath First Commercial Lab to Offer URO17™, Innovative New Biomarker

PLAINVIEW, N.Y. and CAMPBELL, Calif., July 25, 2019 /PRNewswire/ -- Acupath Laboratories, Inc., a leading provider of sub-specialized anatomic and molecular pathology services, and KDx Diagnostics, Inc., a leading developer of bladder cancer tests, today announced that KDx has licensed Acupath to incorporate its URO17™ ...more

05/18/19

Validation of a Novel Cytologic Biomarker for Urothelial Carcinoma

Cytology
and cystoscopy have limited sensitivity and specificity for the diagnosis of urothelial carcinoma ( due to inflammatory atypia, sampling errors, and other clinicopathologic factors that may...more

11/15/18

Keratin 17 is a Sensitive and Specific Biomarker of Urothelial Neoplasia

The current study aimed to evaluate keratin 17 (K17), an oncoprotein that drives cell cycle progression in cancers of multiple anatomic sites as a diagnostic biomarker of urothelial neoplasia in bladder biopsies and in urine cytology specimens...more

10/26/18

Keratin 17 is a sensitive and specific biomarker of urothelial
neoplasia

There is a clinical need to identify novel biomarkers to improve diagnostic accuracy for the detection of urothelial tumors.
The current study aimed to evaluate keratin 17 (K17), an oncoprotein that drives cell cycle progression in cancers...more

MUA_EAU2020_main1_edited.jpg

EAU'20 ( Cancelled Event Due to COVID-19)

 The biggest urological event in Europe

logpaj.png

LUGPA

LUGPA is the only nonprofit urology trade association in the US.

WHALLLLLE.png

WSAUA

A non-profit organization (501 c6) composed of Urologists and Urology professionals joining together to further their mission.

AACR

The American Association for Cancer Research

0.jpeg